| Gilead Sciences Switzerland Sàrl - Sunlenca, Filmtabletten | | 68386 | | 01 | | Sunlenca | | Filmtabletten | | J05AX31 | | Lenacapavir | | 07.07.2023 | | |
| | Composition | | lenacapavirum 300 mg ut lenacapavirum natricum, copovidonum, poloxamerum 407, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (nigrum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 17.93 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Lenacapavirum | 300 mg |
| | BAG: Active Agent | Dose |
|---|
| Lenacapavirum | 300 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copovidonum | | | | E 171 | | color. | | E 172 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Mannitol | | | | Poloxamer | 407 | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 5 | 3115.55 | 3404.75 | A | SL | No |
|
|
